Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence

The current classification of ductal carcinoma in situ (DCIS) is based on nuclear grade, architectural differentiation and the presence of necrosis that does not adequately predict the likelihood of recurrence after breast conserving therapy; therefore, there is a critical need to identify novel pre...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Witkiewicz, Agnieszka K, Freydin, Boris, Chervoneva, Inna, Potoczek, Magdalena, Rizzo, Wendy, Rui, Hallgeir, Brody, Jonathan R, Schwartz, Gordon F, Lisanti, Michael P
Formato: Artigo
Idioma:Inglês
Publicado: Landes Bioscience 2010
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3040854/
https://ncbi.nlm.nih.gov/pubmed/20574156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.10.4.12449
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares